-
Overview
-
Experience
Introduction
Michael handles district court patent litigation and proceedings before the U.S. Patent and Trademark Office in a variety of technologies in the life sciences industry.
With more than 35 years of practice, Michael J. Wise handles district court patent litigation, inter partes review, and interference proceedings before the U.S. Patent Trial and Appeal Board. He also advises clients on patent counseling and portfolio management, with a focus on the life sciences industry. Michael regularly works with academic institutions, research institutions, emerging companies, privately held companies, and publicly traded companies with respect to protecting and enforcing their IP rights. He has experience with a wide variety of technologies, including biologic and small molecule therapeutics, diagnostics, medical devices, software, and electronics.
Michael has been recognized by Chambers Global for over a decade.He has been an active member of the Southern California Biomedical Council for more than two decades. Michael served as chair of the annual SoCalBio Investor Conference and currently serves as secretary of the board of directors.
Education & credentials
- Loyola Law School, Los Angeles, J.D., cum laude, Order of the Coif, 1989
- University of California, Los Angeles, B.S., Biology, 1985
- California
- U.S. Patent and Trademark Office
- U.S. Court of Appeals for the Federal Circuit
- U.S. District Court for the Northern District of California
- U.S. District Court for the Central District of California
- U.S. District Court for the Southern District of California
Professional recognition
Named Life Sciences Expert of the Year in California, USA, by Leaders in Law, 2026
Recognized as a "Top Biotech and Life Sciences Attorney" by Attorney Intel, 2024
Listed in Chambers Global Guide, 2013-2026
Ranked by Chambers USA as "America's Leading Lawyer" for Life Sciences: IP/Patent Litigation in California, 2012-2026
Listed in Best Lawyers in America: Biotechnology and Life Sciences Practice; Litigation - Intellectual Property, 2016-2026; Patent Law, 2023-2026
Ranked in Intellectual Asset Management Patent 1000, 2012-2025; Litigation Silver Band, 2016-2025; Litigation Bronze Band, 2012-2015
American Bar Foundation Fellow, 2020-2023
Recognized as an IP Star by Managing IP, 2013-2025
Named "Top Intellectual Property Attorney in California" by the Daily Journal, 2018, 2020-2022
Listed by Los Angeles Magazine as “Southern California Super Lawyers,” 2013-2022
Listed in Who's Who Legal: Life Sciences - Patent Litigation, 2017-2021, 2024
Recognized as one of the "2020 Top Lawyers in Southern California" by Los Angeles Times, 2020
Best Lawyers’ Los Angeles "Biotechnology and Life Sciences Practice, Lawyer of the Year," 2018, 2020
Ranked by LMG Life Sciences as an "Intellectual Property Star", 2019-2025
Recognized as a “Top Attorney in Southern California" by Los Angeles Magazine, 2019
Recognized as "Life Sciences, Lawyer of the Year, USA," by Lawyer Monthly Legal, 2018
*Peer Review Rated AV in Martindale-Hubbell
(AV®, BV® and CV® are registered certification marks of Reed Elsevier Properties Inc., used in accordance with the Martindale-Hubbell certification procedures, standards and policies.)
Impact
- Southern California Biomedical Council, Secretary, 2004-present
- Southern California Biomedical Council, Board Member, 2000-present
Patent Counseling and Procurement for Shanghai Benemae Pharmaceutical Corporation
Providing advice on a variety of IP-related issues including patent procurement, general IP strategies and internal IP management.
Patent Counseling for Xcelom Limited
Assisting in the enforcement of its licensed patent rights in Hong Kong related to use of random massively parallel sequencing for detection of fetal aneuploidy.
Patent Procurement and Litigation Counseling for Ruyan
Managed the company’s global patent portfolio and enforced patents to protect its vapor technology.
R. J. Reynolds v. Fontem Ventures B.V., et al.
Patent Trial and Appeal Board
Represented patent owner Fontem in defending twenty-six inter partes review petitions of electronic cigarette patents. Obtained multiple favorable Board decisions prior to settlement.
Nu Mark, LLC v. Fontem Ventures B.V., et al.
Patent Trial and Appeal Board
Represented patent owner Fontem in defending twenty-five inter partes review petitions of electronic cigarette patents. Obtained multiple favorable Board decisions prior to settlement.
Lo et al. (Sequenom, Inc.) v. Quake, Et Al (Illumina, Inc), Interference Nos. 105,920, 105,922-924.
Board of Patent Appeals and Interferences
Represented Party Lo in a series of Interferences before the Board of Patent Appeal and Interferences between Parties Lo and Quake involving the use of random massively parallel sequencing for detection of fetal aneuploidy in a maternal blood sample. Obtained judgment for Party Lo on priority because Party Quake’s involved patent and applications lacked written description support for the involved claims.
Van der Hoeven Horticultural Projects B.V. v. Glass Investment Projects, Inc.
U.S. Court of Appeals for the Federal Circuit
Represented patent owner on appeal following an IPR decision upholding challenged claims over the prior art. Obtained summary affirmance upholding favorable judgment on appeal. Case No. 18-2234
Fontem Ventures B.V., et al. v. R. J. Reynolds Vapor Company, Case Nos. 16-cv-1255-CCE, 16-cv-1257-CCE, 16-cv-1258-CCE, 17-cv-175-CCE
U.S. District Court for the Middle District of North Carolina
Representing plaintiff Fontem in enforcing fifteen electronic cigarette patents in four infringement cases. Cases are settled.
Fontem Ventures B.V., et al. v. Nu Mark, LLC, Case Nos. 16-cv-1259-CCE, 16-cv-1261-CCE
U.S. District Court for the Middle District of North Carolina
Represented plaintiff Fontem in enforcing sixteen electronic cigarette patents in two consolidated infringement cases. Cases settled.
Fontem Holdings 1 B.V. & Fontem Ventures B.V. v. Njoy, Inc. et al., Case No. CV14-1645-GW (lead case)
U.S. District Court for the Central District of California
Represented plaintiff Fontem in enforcing nine electronic cigarette patents in twenty-four consolidated patent cases against eight of the largest e-cigarette companies operating in the United States. Cases settled.
Patent Procurement, Counseling and Due Diligence for City of Hope
Patent preparation, prosecution, and counseling related to small molecule therapeutics, biotechnology therapeutics diagnostics and medical devices.
Patent Procurement, Counseling and Due Diligence for Editas Medicine
Patent counsel for publicly traded pharmaceutical company developing clinical applications for genome editing. Representation includes patent procurement and due diligence relating to financing.
Patent Procurement, Counseling and Due Diligence for Eloxx Pharmaceuticals
Comprehensive patent counsel for publicly traded pharmaceutical company developing small molecule therapeutics for treatment of cystic fibrosis and other premature stop codon-related diseases. Representation includes patent procurement, management of licensed and original patent portfolios, and due diligence relating to licensing and financing.
Latest news, deals and awards
Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.
-
News Perkins Coie is pleased to announce that 39 of its Intellectual Property (IP) lawyers were recognized by Intellectual Asset Management in the 2026 IAM Patent 1000 list, which recognizes the world's leading, best-in-class patent professionals.
June 02, 2026
Discover more -
News Perkins Coie Partners and Practice Groups Ranked in the 2026 Chambers Global Guide
February 12, 2026
Discover more -
News Managing IP Names 22 Perkins Coie Lawyers IP STARS and Top 250 Women in IP; Recognized as a Leading Trademark Firm
June 11, 2025
Discover more -
News Perkins Coie Ranks Among Top Law Firms in 2025 Chambers USA
June 05, 2025
Discover more -
News IAM Patent 1000 Recognizes Perkins Coie and 39 Lawyers as Patent Leaders in US and Asia
June 03, 2025
Discover more -
News Perkins Coie Partners and Practice Groups Ranked in the 2025 Chambers Global Guide
February 20, 2025
Discover more